Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation (Details Narrative)

v2.4.0.8
Basis of Presentation (Details Narrative) (Pharma [Member])
3 Months Ended
Mar. 31, 2014
Pharma [Member]
 
Acquired percentage of issued and outstanding common stock 100.00%
Shares of common stock acquired 33,229,093
Percentage of shares issued and outstanding acquired on post-acquisition basis 53.00%